Home | Articles
Published on:January 2023
Indian Journal of Pharmaceutical Education and Research, 2023; 57(1):301-307
Commentary | doi:10.5530/001954641939

“Drug Repurposing” Policies and Statutes: Lessons from the COVID-19 Pandemic: A Review


Authors and affiliation (s):

Srividya Ravi*, Sammita Jadhav, Ravindra Ghooi

Symbiosis Institute of Health Sciences, Symbiosis International (Deemed University), Gram-Lavale, Mulshi, Pune, Maharashtra, INDIA.

Abstract:

Introduction: Repurposed drugs are not eligible for patent protection in India vide Sec 3 (d) of the Indian Patent Act, 1970. The data generated to establish the therapeutic efficacy of the repurposed drugs for the new indication are not eligible for data exclusivity under the provisions of the Drugs and Cosmetic Act, 1940. However, repurposed drugs possess immense advantages, especially when compared to the traditional route of drug discovery. Marketing repurposed drugs is fraught with challenges, and means to overcome them need to be facilitated. Methodology: A review of literature regarding provisions available to protect repurposed candidates through various routes globally were studied including policies, special committee reports as well as case laws. Results: A brief tenure of data exclusivity for repurposed candidates as provided in statutes in the US and EU appears to be an attractive route of protection of such inventions. This will encourage and incentivize drug research by this route and eventually lead to a fulfillment of India being a preferred destination for not only pharma manufacturing, but also research.

Keywords: Repurposing drugs, Patents, Data exclusivity, COVID-19, Drug discovery, Drug development in India.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs